tiprankstipranks
Nuvation Bio (NUVB)
NYSE:NUVB
US Market

Nuvation Bio (NUVB) Financial Statements

151 Followers

Nuvation Bio Financial Overview

Nuvation Bio's market cap is currently ―. The company's EPS TTM is $-0.314; its P/E ratio is -9.54; Nuvation Bio is scheduled to report earnings on August 1, 2024, and the estimated EPS forecast is $-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -20.20M$ -20.83M$ -19.65M$ -20.64M$ -26.70M
EBITDA$ -20.14M$ -20.78M$ -23.02M$ -23.80M$ -28.80M
Net Income Common Stockholders$ -14.79M$ -13.79M$ -18.55M$ -20.64M$ -19.14M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 596.98M$ 611.21M$ 619.34M$ 630.90M$ 646.61M
Total Assets$ 613.13M$ 621.48M$ 630.87M$ 641.41M$ 657.06M
Total Debt$ 3.53M$ 4.01M$ 4.46M$ 3.68M$ 3.97M
Net Debt$ -593.44M$ -607.21M$ -614.88M$ -627.22M$ -642.64M
Total Liabilities$ 19.08M$ 16.36M$ 19.28M$ 16.78M$ 15.99M
Stockholders Equity$ 594.04M$ 605.12M$ 611.59M$ 624.60M$ 641.07M
Cash Flow-
Free Cash Flow$ -15.73M$ -15.04M$ -16.21M$ -17.54M$ -19.31M
Operating Cash Flow$ -15.70M$ -15.03M$ -16.18M$ -17.52M$ -19.30M
Investing Cash Flow$ 7.54M$ 33.16M$ -9.59M$ 37.35M$ -52.00M
Financing Cash Flow$ 21.00K$ 120.00K$ 77.00K$ 133.00K$ 298.00K
Currency in USD

Nuvation Bio Earnings and Revenue History

Nuvation Bio Debt to Assets

Nuvation Bio Cash Flow

Nuvation Bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis